Metabolite details
Reactome pathways
- R-HSA-1236973 - Cross-presentation of particulate exogenous antigens (phagosomes)
- R-HSA-1236975 - Antigen processing-Cross presentation
- R-HSA-1280218 - Adaptive Immune System
- R-HSA-1430728 - Metabolism
- R-HSA-156580 - Phase II - Conjugation of compounds
- R-HSA-156581 - Methylation
- R-HSA-162582 - Signal Transduction
- R-HSA-1643685 - Disease
- R-HSA-168256 - Immune System
- R-HSA-189445 - Metabolism of porphyrins
- R-HSA-189483 - Heme degradation
- R-HSA-191273 - Cholesterol biosynthesis
- R-HSA-2046104 - alpha-linolenic (omega3) and linoleic (omega6) acid metabolism
- R-HSA-2046105 - Linoleic acid (LA) metabolism
- R-HSA-2046106 - alpha-linolenic acid (ALA) metabolism
- R-HSA-209776 - Metabolism of amine-derived hormones
- R-HSA-209968 - Thyroxine biosynthesis
- R-HSA-211859 - Biological oxidations
- R-HSA-211897 - Cytochrome P450 - arranged by substrate type
- R-HSA-211916 - Vitamins
- R-HSA-211935 - Fatty acids
- R-HSA-211945 - Phase I - Functionalization of compounds
- R-HSA-211957 - Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2
- R-HSA-211958 - Miscellaneous substrates
- R-HSA-211979 - Eicosanoids
- R-HSA-211981 - Xenobiotics
- R-HSA-211999 - CYP2E1 reactions
- R-HSA-2142753 - Arachidonate metabolism
- R-HSA-2142816 - Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)
- R-HSA-217271 - FMO oxidises nucleophiles
- R-HSA-5362517 - Signaling by Retinoic Acid
- R-HSA-5365859 - RA biosynthesis pathway
- R-HSA-556833 - Metabolism of lipids
- R-HSA-5579011 - Defective CYP2U1 causes SPG56
- R-HSA-5579015 - Defective CYP26B1 causes RHFCA
- R-HSA-5579019 - Defective FMO3 causes TMAU
- R-HSA-5579029 - Metabolic disorders of biological oxidation enzymes
- R-HSA-5668914 - Diseases of metabolism
- R-HSA-71291 - Metabolism of amino acids and derivatives
- R-HSA-8957322 - Metabolism of steroids
- R-HSA-8978868 - Fatty acid metabolism
- R-HSA-9006931 - Signaling by Nuclear Receptors
- R-HSA-983169 - Class I MHC mediated antigen processing & presentation
Observed in studies
- Untargeted metabolomics to understand the basis of phenotypic differences in amphotericin B-resistant Leishmania parasites
- Distribution of RESV and its metabolite peaks in mouse tissues after oral and skin administration
- Resveratrol metabolism in HepG2 (human hepatocytes), HaCaT (human keratinocytes), and C2C12 (mouse myoblasts)
- Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Escherichia coli assays)
- Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
- Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Klebsiella pneumoniae assays)
- Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Streptococcus pneumoniae assays)
- Host autophagy mediates organ wasting and nutrient mobilization for tumor growth.
- Multiomics of tomato glandular trichomes reveals distinct features of central carbon metabolism supporting high productivity of specialized metabolites
- F1Fo-ATP synthase subunit determines lethal pathogenic fungi infection
- The functional role of OGDH for maintaining mitochondrial respiration and identity of primed human embryonic stem cells
- Homeostasis of the biosynthetic E. coli metabolome
- TFAM loss induces nuclear actin assembly upon mDia2 malonylation to promote liver cancer metastasis.
- Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors
- Unexpected similarities between the Schizosaccharomyces and human blood metabolomes, and novel human metabolites (Blood fraction)
- Unexpected similarities between the Schizosaccharomyces and human blood metabolomes, and novel human metabolites (Blood plasma and RBC fractions)
Observed in differential profiles
- G1_Wild_Type_vs_G2_AmBRAcl1
- Control_Oral_Blood_vs_RESV_Oral_Blood
- Control_Oral_Blood_vs_RESV_Oral_Blood
- HepG2_0uM_vs_HepG2_200uM
- HepG2_0uM_vs_HepG2_200uM
- HepG2_0uM_vs_HepG2_200uM
- HepG2_0uM_vs_HepG2_200uM
- HepG2_0uM_vs_HepG2_200uM
- HepG2_0uM_vs_HepG2_200uM
- RPMI_B36_vs_Pooled_Sera_B36
- G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
- G1_Klebsiella_pneumoniae_AJ218_RPMI_vs_G2_Klebsiella_pneumoniae_AJ218_Pooled_sera
- G1_Pooled_Sera_Blood_4559_vs_G2_RPMI_Glucose_Blood_4559
- G1_Frt_Ctrl_Day_6_vs_G3_Rasv12_Scrib_Day_6
- Solanum_habrochaites_leaf_vs_glandular_trichome
- WT_vs_16R
- Wild_Type_vs_Gene_Knockdown
- Glu_BW25113_vs_Pyr_BW25113
- Control_Cytoplasm_vs_TFAM_Knockdown_Cytoplasm
- Wild_Type_vs_Gene_Knockout
- Human_Blood_vs_Human_Plasma
- Human_Blood_vs_Human_Plasma
- Human_Blood_vs_Human_Plasma
- Blood_vs_Plasma
- Blood_vs_Plasma